These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7120289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A prodrug of ADTN: selectivity of dopaminergic action and brain levels of ADTN.
    Horn AS, Kelly P, Westerink BH, Dijkstra D.
    Eur J Pharmacol; 1979 Nov 23; 60(1):95-9. PubMed ID: 574829
    [Abstract] [Full Text] [Related]

  • 4. Selective storage in vivo of 5,6-ADTN in dopamine-rich areas of the rat brain.
    Westerink BH, Dijkstra D, Feenstra MG, Horn AS, Rollema H.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):115-21. PubMed ID: 7398758
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic prodrugs: brain concentrations and neurochemical effects of 5,6- and 6,7-ADTN after administration as dibenzoyl esters.
    Westerink BH, Dijkstra D, Feenstra MG, Grol CJ, Horn AS, Rollema H, Wirix E.
    Eur J Pharmacol; 1980 Jan 11; 61(1):7-15. PubMed ID: 7353583
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.
    Rollema H, Feenstra MG, Grol CJ, Lewis MH, Staples L, Mailman RB.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr 11; 332(4):338-45. PubMed ID: 3736679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Binding of [3H]ADTN to rat striatal membranes.
    Templeton WW, Woodruff GN.
    Biochem Pharmacol; 1982 Apr 15; 31(8):1629-32. PubMed ID: 6124259
    [Abstract] [Full Text] [Related]

  • 10. The significance of COMT activity in controlling dopamine agonist levels in brain and serum: studies with a prodrug and a metabolite of 6,7-ADTN.
    Rollema H, Westerink BH, Mulder TB, Dijkstra D, Feenstra MG, Horn AS.
    Eur J Pharmacol; 1980 Jun 27; 64(4):313-23. PubMed ID: 7389825
    [Abstract] [Full Text] [Related]

  • 11. Effects of ADTN and various other 2-aminotetralin derivatives on the efflux of 3H-dopamine from rat striatal slices.
    Mulder AH, Braakhuis B, De Regt V, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1980 Jun 27; 64(4):349-55. PubMed ID: 7389827
    [Abstract] [Full Text] [Related]

  • 12. Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists.
    Cannon JG, True CD, Long JP, Bhatnagar RK, Leonard P, Flynn JR.
    J Med Chem; 1989 Sep 27; 32(9):2210-4. PubMed ID: 2570153
    [Abstract] [Full Text] [Related]

  • 13. Facile syntheses of potent dopaminergic argonists and their effect on neurotransmitter release.
    Horn AS, Grol CJ, Dijkstra D, Mulder AH.
    J Med Chem; 1978 Aug 27; 21(8):825-8. PubMed ID: 29125
    [Abstract] [Full Text] [Related]

  • 14. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
    Mulder TB, Grol CJ, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1985 May 28; 112(1):73-9. PubMed ID: 4018139
    [Abstract] [Full Text] [Related]

  • 15. In vivo dopamine receptor binding studies with a non-radioactively labeled agonist, dipropyl-5,6-ADTN.
    Feenstra MG, Rollema H, Mulder TB, Westerink BH, Horn AS.
    Life Sci; 1983 Mar 21; 32(12):1313-23. PubMed ID: 6403788
    [Abstract] [Full Text] [Related]

  • 16. Altered characteristics of striatal [3H]ADTN binding following substantia nigra lesions.
    Hirschhorn ID, Makman MH.
    Eur J Pharmacol; 1982 Sep 10; 83(1-2):61-7. PubMed ID: 7128701
    [Abstract] [Full Text] [Related]

  • 17. In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum.
    Carlsson A, Löfberg L.
    J Neural Transm; 1985 Sep 10; 64(3-4):173-85. PubMed ID: 4086990
    [Abstract] [Full Text] [Related]

  • 18. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P, Woodruff GN, Poat JA.
    Eur J Pharmacol; 1979 Apr 15; 55(2):137-42. PubMed ID: 456412
    [Abstract] [Full Text] [Related]

  • 19. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr 15; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 20. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
    Naiman N, Lyon RA, Bullock AE, Rydelek LT, Titeler M, Glennon RA.
    J Med Chem; 1989 Jan 15; 32(1):253-6. PubMed ID: 2521252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.